http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013204961-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c5dc9ab2a59bc03c0bf4b6dfdf47ade |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f179593aafeda9f6624796abfca0af6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0896e28554e9afd449662e8df4e2e0a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e529a027c1271c767fb1653a4fdbdcb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7a6928138cf309a26fddecba2aee49b |
| publicationDate | 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013204961-A1 |
| titleOfInvention | Lung volume reduction therapy using crosslinked non-natural polymers |
| abstract | One aspect of the invention relates to a hydrogel comprising a nonnatural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogen comprising a non natural polymer comprising a plurality of pendant electrophilic groups and reducing lung volume in a patient comprising the step of administering a hydrogen composition as described herein, Further., hydrogeLs of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a Ling, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema. |
| priorityDate | 2007-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.